Pearl D’Cruz is an accomplished life sciences executive and long-standing member of
Executive Women In Bio, recognized for her deep expertise in product safety,
pharmacovigilance, and process optimization across the biopharmaceutical sector. She has
contributed to strategic business operations; business development; organizational
development; strategic alliances and fund raising projects. Pearl is passionate about advancing
Women’s health initiatives and is active in the Women’s Health Advocates (WHA) community.
She also serves as a reviewer for Springboard Enterprises, supporting emerging women-led
companies and helping accelerate high-potential biotech innovations. She is the Founder of
Pearl Consulting, where she led operations for more than 21 years, providing solution-driven,
process improvement–focused Product Safety and Pharmacovigilance services. ensuring
regulatory rigor, operational efficiency, and patient safety. Throughout her career, Pearl has
served as a Pharmacovigilance Consultant to numerous pharmaceutical and biotechnology
companies such as GSK, Astrazeneca, Medimmune, Human Genome Sciences, Macrogenics,
where she has been valued for her strategic insight, cross-functional leadership, and ability to
implement robust safety systems tailored to organizational needs.
